Mumbai: US-based generic pharma major Mylan has sold its 5.64% share in Biocon Ltd within 6 months of getting it.…
Browsing: Biocon
New Delhi: This has been a significant milestone in the long-term process of changing the leadership of the company because…
Mumbai: With Novo Nordisk’s Semaglutide patent due for expiry in various markets, India’s leading generic drugs manufacturer Biocon has signed…
New Delhi: Bangalore Outer Ring Road (ORR) is once again in the limelight because of traffic congestion, particularly around the…
New Delhi: Biocon, an Indian pharmaceuticals giant, registered Rs 3,516 crore in revenues for Quarter 1 of FY 2024. An official…
